Evaluation of anti-CD160 antibodies in "in vivo" models.

Investigadores/as

Filtrar

Mª LUISA DEL

RÍO GONZÁLEZ

Responsable

JOSE IGNACIO

RODRÍGUEZ BARBOSA

Responsable

Publicaciones relacionadas con el proyecto (2)

Mostrar por tipología

2023

1. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression

   Frontiers in Immunology

2022

1. The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection

   Translational Research